Prophylaxis can minimize rash from targeted therapies

Commentary

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)49
Number of pages1
JournalOncology Report
Issue numberWINT
StatePublished - Dec 2009

Fingerprint

Exanthema
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Prophylaxis can minimize rash from targeted therapies : Commentary. / Loprinzi, Charles Lawrence.

In: Oncology Report, No. WINT, 12.2009, p. 49.

Research output: Contribution to journalArticle

@article{325a613e68b043339a870d2795869f21,
title = "Prophylaxis can minimize rash from targeted therapies: Commentary",
author = "Loprinzi, {Charles Lawrence}",
year = "2009",
month = "12",
language = "English (US)",
pages = "49",
journal = "Oncology Report",
issn = "1548-5323",
publisher = "Elsevier BV",
number = "WINT",

}

TY - JOUR

T1 - Prophylaxis can minimize rash from targeted therapies

T2 - Commentary

AU - Loprinzi, Charles Lawrence

PY - 2009/12

Y1 - 2009/12

UR - http://www.scopus.com/inward/record.url?scp=78650266024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650266024&partnerID=8YFLogxK

M3 - Article

SP - 49

JO - Oncology Report

JF - Oncology Report

SN - 1548-5323

IS - WINT

ER -